Newborn Screening and Early Treatment for Rare Genetic Disorder, LA BioMed Reveals  
12/29/2010 7:46:27 AM

(Ivanhoe Newswire) – Researchers believe that newborn screening and early treatment for a rare genetic disorder, mucopolysaccharidosis type I (MPS I), is needed so that enzyme replacement therapy can begin at birth and eliminate all the symptoms associated with MPS I.